USA Jefferson Pharmaceutical Limited – Trademark Portfolio
Entity Type: 03
USA Jefferson Pharmaceutical Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include VISSOIEN and NEURRISCZZ. The owner is based in Denver, CO.
1312 17th Street, Suite 600
Denver, CO 80202
Showing of trademarks Trademarks
Trademark Classifications
USA Jefferson Pharmaceutical Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does USA Jefferson Pharmaceutical Limited have?
USA Jefferson Pharmaceutical Limited has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.
What trademark classes does USA Jefferson Pharmaceutical Limited file in?
USA Jefferson Pharmaceutical Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are USA Jefferson Pharmaceutical Limited's most well-known trademarks?
USA Jefferson Pharmaceutical Limited's registered trademark portfolio includes well-known marks such as VISSOIEN and NEURRISCZZ. These are among 2 currently registered trademarks in the portfolio.
What is USA Jefferson Pharmaceutical Limited's trademark registration success rate?
USA Jefferson Pharmaceutical Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.